Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Precision Optics Corporation ( (POCI) ).
On March 27, 2026, Precision Optics Corporation, Inc. entered into an underwriting agreement with Lucid Capital Markets, LLC for an underwritten public offering of 2,777,777 shares of common stock at $3.60 per share, with a 45‑day over‑allotment option for an additional 416,667 shares. The offering, which closed on March 30, 2026 under an effective Form S‑3 shelf registration, generated expected net proceeds of about $10.7 million, earmarked for working capital and general corporate purposes, and included issuance of warrants to the underwriter and customary underwriting discounts, expenses and indemnification provisions that modestly dilute existing shareholders while strengthening the company’s capital position.
The underwriter received a discount of up to 6.5% of gross proceeds plus expense reimbursement capped at $90,000, and was granted warrants to purchase up to 159,722 shares at an exercise price of $4.21 per share exercisable from March 30, 2026 through March 27, 2031. Precision Optics announced the proposed offering on March 26, 2026 and its pricing on March 27, 2026, signaling an effort to capitalize on public markets to fund ongoing operations and strategic needs across its medical and defense/aerospace optics portfolio.
The most recent analyst rating on (POCI) stock is a Sell with a $4.00 price target. To see the full list of analyst forecasts on Precision Optics Corporation stock, see the POCI Stock Forecast page.
Spark’s Take on POCI Stock
According to Spark, TipRanks’ AI Analyst, POCI is a Neutral.
The score is held down primarily by weak financial performance (severe margin compression, widening losses, and ongoing cash burn). Technicals add modest pressure with the stock below key longer-term moving averages and negative MACD, while valuation is constrained by losses (negative P/E). The earnings call provides some offset via raised revenue guidance and operational improvements, but EBITDA guidance deterioration and near-term liquidity/financing risk temper the upside.
To see Spark’s full report on POCI stock, click here.
More about Precision Optics Corporation
Precision Optics Corporation, Inc., founded in 1982 and listed on NASDAQ as POCI, is a vertically integrated designer and manufacturer of advanced optical instruments serving the healthcare and defense/aerospace industries. The company leverages proprietary micro‑optics, 3D imaging and digital imaging technologies to support next‑generation medical devices, minimally invasive surgery, 3D endoscopy and high‑specification defense applications.
Average Trading Volume: 24,103
Technical Sentiment Signal: Sell
Current Market Cap: $32.35M
Find detailed analytics on POCI stock on TipRanks’ Stock Analysis page.